Tacitus Therapeutics
New York
About Tacitus Therapeutics
Tacitus Therapeutics is a clinical-stage biotechnology company dedicated to therapies using proprietary cell expansion, differentiation, and engineering platform technologies that overcome the limitations of traditional cell transplantation. The company was founded in 2019 and is headquartered in NYC.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $5.0M
- Last round: Series Unknown (Dec 2019)
- Website: tacitustherapeutics.com
Industries & Categories
Biotechnology, Health Care, Therapeutics
Canonical: https://fsome.com/organization/tacitus-therapeutics-186833 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.